EQUASYM

This brand name is authorized in Germany, Spain, Finland, Ireland, Netherlands, United Kingdom

Active ingredients

The drug EQUASYM contains one active pharmaceutical ingredient (API):

1	Methylphenidate UNII 4B3SC438HI - METHYLPHENIDATE HYDROCHLORIDE
	Methylphenidate HCl is a mild central nervous system (CNS) stimulant. The mode of therapeutic action in Attention Deficit Hyperactivity Disorder (ADHD) is not known. Methylphenidate is thought to block the reuptake of noradrenaline and dopamine into the presynaptic neurone and increase the release of these monoamines into the extraneuronal space.
	Read more about Methylphenidate

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
EQUASYM Modified release capsule, hard	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
N06BA04	Methylphenidate	N Nervous system → N06 Psychoanaleptics → N06B Psychostimulants, agents used for ADHD and nootropics → N06BA Centrally acting sympathomimetics
Discover more medicines within N06BA04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
DE	Bundesinstitut für Arzneimittel und Medizinprodukte	03806235, 03806264, 03806287, 06681596, 06681604, 07350016, 07350022, 07350039, 17395646, 17395652
ES	Centro de información online de medicamentos de la AEMPS	76060, 76061, 76076, 77163, 77164
FI	Lääkealan turvallisuus- ja kehittämiskeskus	023131, 023410, 023412
GB	Medicines & Healthcare Products Regulatory Agency	185774, 185778, 185789, 373632, 373635, 373638, 376358, 376360, 376362, 90986, 90990, 90996
IE	Health Products Regulatory Authority	56983, 56990, 56996
NL	Z-Index G-Standaard, PRK	105376, 82228, 82236, 82244, 83062